SOLSTICE NEUROSCIENCES INC has a total of 21 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ARACHNOVA THERAPEUTICS LTD, CORTRIA CORP and SHANGHAI INST OF CYTOBIOLOGY C.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Cuba | 1 | |
#6 | Hong Kong | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Norway | 1 | |
#10 | Slovenia | 1 | |
#11 | Slovakia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Peptides | |
#5 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Hirtzer Pamela | 9 |
#2 | Joseph Shaji | 9 |
#3 | Moyer Elizabeth | 9 |
#4 | Marin Bret | 9 |
#5 | Garcia Sheryl Ann | 9 |
#6 | O'Brien Christopher | 2 |
Publication | Filing date | Title |
---|---|---|
WO2010051038A1 | Compositions of activated botulinum holotoxin type b (150 kd) | |
US2010112005A1 | Compositions of activated botulinum toxin type B | |
US2010034854A1 | Compositions of activated botulinum holotoxin type B (150 KD) | |
WO2010016895A1 | Compositions of activated botulinum toxin type b |